Clinical Trials in Boston

Showing 4941-4960 of 17,836 trials

Intervening in Food Insecurity to Reduce and Mitigate (InFoRM) Childhood Obesity

NCT05586269

The goals of this study are to 1) pilot the feasibility of a novel meal kit delivery intervention in families and children with food insecurity and obesity and 2) evaluate the implementation of the pilot intervention.

Pediatric ObesityNutrition DisordersOvernutrition, Child+1 more

Boston Children's Hospital59 participantsStarted Feb 2023

Boston, Massachusetts, United States

COMPLETEDNA< 1 mile

Soy Nuts and Cardiovascular Risk in Postmenopausal Women

NCT01740076

To determine the effect of a whole soy food, dietary soy nuts, on blood pressure, lipid levels, inflammation and menopausal symptoms in postmenopausal women.

Postmenopausal Women

Beth Israel Deaconess Medical Center84 participantsStarted Sep 2001

Boston, Massachusetts, United States

Not Yet RecruitingPhase 3< 1 mile

Efficacy and Safety of MSC-NTF (NurOwn) in Participants With Early Symptomatic ALS and Moderate Disease Presentation in ALS (ENDURANCE STUDY)

NCT06973629

The goal of this two-part clinical trial is: 1\) to evaluate the safety and efficacy of Debamestrocel - MSC-NTF (NurOwn) compared to placebo in participants with early symptomatic ALS and moderate disease presentation in ALS; followed by 2) further evaluation by providing NurOwn to all participants in an open label extension period. Researchers will compare NurOwn to a placebo (a look-alike substance that contains no drug) to evaluate the efficacy of NurOwn compared to placebo in the treatment of participants with ALS. Participants will: Receive NurOwn or a placebo every 8 weeks for 24 weeks. After that, every participant will receive NurOwn every 8 weeks for an additional 24 weeks. They will visit the clinic approximately every 8 weeks for checkups and tests.

Amyotrophic Lateral Sclerosis (ALS)Amyotrophic Lateral Sclerosis

Brainstorm-Cell Therapeutics200 participantsStarted Jun 2025

Phoenix, Arizona, United States • La Jolla, California, United States • Los Angeles, California, United States +12 more locations

Intervening in Food Insecurity to Reduce and Mitigate (InFoRM) Childhood Obesity

Soy Nuts and Cardiovascular Risk in Postmenopausal Women

Efficacy and Safety of MSC-NTF (NurOwn) in Participants With Early Symptomatic ALS and Moderate Disease Presentation in ALS (ENDURANCE STUDY)

Find Trials by Condition in Boston

ThRombectomy In Mild Ischemic Stroke With a Visible Intracranial veSsel Occlusion

A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL.

Multi-Component Breath Alcohol Intervention

Treatment of Pregnant Women With OUD

Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune Hemolytic Anemia (wAIHA)

A Registry for People With T-cell Lymphoma

Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria

Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery

Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ADCT-901 in Participants With Selected Advanced Solid Tumors

Safety and Efficacy Study of CFI-402411 in Subjects With Advanced Solid Malignancies

Study of Safety, Tolerability and Efficacy of PBGM01 in Pediatric Participants With GM1 Gangliosidosis

Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis

A RCT Evaluating the Clinical Benefit of a Silver Dressing in the Treatment of Venous Leg Ulcers

Prospective Natural History Study of Retinitis Pigmentosa

A Study of Mipasetamab Uzoptirine (ADCT-601) in Participants With Solid Tumors